Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Update on bTB vaccine

MPs warn vaccine is not a complete solution

In a report published on June 5, the Environment, Food and Rural Affairs Committee (EFRACom), warned that vaccination will not provide a complete solution to bovine TB (bTB).

Launching the report into the progress of a vaccine, EFRACom chair Anne McIntosh said vaccination is expensive, does not guarantee protection and will not on its own solve the problems caused by bTB.

"The Government is right to invest millions of pounds in developing vaccines against bovine TB. We should use every tool to combat this disease, but vaccination alone will not, at least in the short-term, provide a complete solution.

"Vaccines have no impact on already infected animals, offer a range of protection to those that aren’t infected, and will be expensive to deploy."

Small-scale studies in Ethiopia and Mexico have found the protective effect of a cattle vaccine to be 56-68 per cent. EFRACom warn that this is not a high enough level of protection to immediately solve the problem.

The injectable badger vaccine, which has been available since 2010, "could create a healthier badger population", according to Ms McIntosh. It is, however, expensive, she added, meaning it should be used in areas where it will have the most impact.

An oral baited badger vaccine is felt to be "the most likely way to create a healthy badger population," offering a cheaper and more practical alternative to vaccination.

Concluding, Ms McIntosh called on the government to investigate whether the gamma interferon test - a blood test that is more sensitive than the skin test currently relied upon - could be used more widely to test for bTB, despite the cost.

She added that ongoing research projects could make a real difference in eradicating the disease in the UK, and the government's continuing investment in this research is crucial.

 

Related News
Reseach offers hope for bTB vaccine
Cattle bTB vaccine unlikely until 2023

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.